Ready to Register?

MyLawCLE All-Access Pass

Best choice

Add the All-Access Pass and get this program —
plus 1,000+ live CLE programs every year.


All specialty & ethics credits included
38 practice areas
New sections: AI & the Law, Practice Management
100s of current and trending legal topics
Nationally recognized and highly experienced presenters

$395 / year — this program included
Register with the All-Access Pass

This program + 1,000+ CLE programs, all year

Or register for just this program

On-Demand Video

Recorded access + self-study credit.
$195 Register

Digital Evidence at Trial: Mastering Impeachment Strategy and Admissibility Before You Step Into the Courtroom

Master digital evidence admissibility and impeachment strategy. Authenticate online statements, deploy cross-examination at the right moment, and protect witness credibility confidently at trial.

2026-04-02 14:00:00

Program Details

2026-04-02 14:00:00

Program Details

2026-04-02 14:00:00

Over 1,000+ webinars

2026-04-02 14:00:00

Course Overview

The AI Arrived Inside the Software You Already License

2026-04-02 14:00:00

Microsoft embedded Copilot directly into the Word, Outlook, Teams, and Excel licenses most firms already pay for — which means attorneys are running generative AI against privileged client data whether or not the firm sanctioned it or wrote a single policy. ABA Formal Opinion 512 now attaches concrete duties to that use — competence, confidentiality, candor to the tribunal, reasonable billing, and supervision of staff — while 53% of legal professionals report their firm has no AI policy or none they know of. Any lawyer whose practice licenses Microsoft 365 is already exposed, and the 36% of civil litigators using AI personally are operating on assumptions the rules no longer support. This program maps Opinion 512 onto specific Copilot workflows, separates Microsoft’s tenant boundaries from public tools like ChatGPT, weighs Copilot against Harvey, LexisAI, and Clearbrief, and hands attendees a governance framework and an ethics checklist. You leave able to draft a firm-wide AI policy, decide when Copilot displaces public tools for privileged work, and disclose AI use to courts and clients defensibly.

Format

CLE Credit

2h CLE Credits

Level

Intermediate

Length

2

Key topics that will be covered

01
Digital evidence
Authenticate and challenge online statements under federal evidentiary rules.
02
Impeachment use
Distinguish using digital statements for credibility versus substantive admissibility.
03
Trial introduction
Present and respond to digital communications in litigation effectively.
04
Narrative timing
Evaluate whether impeachment strengthens the factfinder’s story at trial.
05
Tone calibration
Optimize impeachment content and timing across different witness categories.
06
Witness protection
Prepare and rehabilitate witnesses against opposing counsel impeachment attempts.

Program schedule

clock 2:00 pm - 3:00 pm EST

Digital Evidence on the Stand: Online Statements Under FRE 613 & 801(d)

Examine how social media posts, texts, emails, and other digital communications are authenticated, introduced, and challenged at trial under FRE 613 and 801(d), distinguishing impeachment use from substantive admissibility in real trial settings.

Christopher G. CampbellChristopher G. Campbell
Breanna FieldsBreanna Fields
Dani MorrisonDani Morrison
Alyssa MoscarinoAlyssa Moscarino
Nick SeccoNick Secco
clock 3:10 pm - 4:10 pm EST

The Art of Impeachment: Impeachment as a Storytelling Device

Master the content, tone, and timing of impeachment as a trial narrative tool, including strategies for determining when to deploy it, calibrating witness-specific approaches, and rehabilitating friendly witnesses after opposing counsel impeaches them.

Christopher G. CampbellChristopher G. Campbell
Breanna FieldsBreanna Fields
Dani MorrisonDani Morrison
Alyssa MoscarinoAlyssa Moscarino
Nick SeccoNick Secco
Christopher G. Campbell

Christopher G. Campbell

DLA Piper

Breanna Fields

Breanna Fields

DLA Piper LLP

Dani Morrison

Dani Morrison

DLA Piper LLP

Alyssa Moscarino

Alyssa Moscarino

Benesch Friedlander Coplan & Aronoff LLP

Nick Secco

Nick Secco

Benesch Friedlander Coplan & Aronoff LLP

Christopher G. Campbell

Christopher G. Campbell

DLA Piper

Christopher G. Campbell is a partner at DLA Piper, where he chairs the firm’s Product Liability and Mass Torts group and co-chairs its Product Liability, Mass Torts & Class Actions group. Drawing on 25 years of experience across every phase of mass tort, class action, and complex product liability litigation, he serves as global, national, and trial counsel for major companies in the pharmaceutical, medical device, automotive, industrial equipment, healthcare, consumer goods, and safety equipment industries, and advises on regulatory, communications, and other strategic matters affecting clients’ business interests and reputations. He writes and speaks regularly on digital evidence, expert witnesses, the attorney-client privilege, trial tactics, and class action trends.

Education & Credentials

Chris earned his J.D. from Harvard Law School in 2000, where he served on the Harvard Negotiation Law Review, the International Law Journal, and the Civil Rights-Civil Liberties Law Review and participated in the Ames Moot Court Competition. He holds a B.S. in Philosophy and English from Austin Peay State University (1997), which named him Outstanding Young Alumnus of the Year in 2002. He is admitted to practice in Georgia and New York.

Recognition & Leadership

Chris is ranked by Chambers USA for Nationwide Product Liability & Mass Torts (Band 5, 2025; Band 6, 2023–2024) and is recognized by The Legal 500 United States as a Leading Lawyer in pharmaceutical and medical device product liability defense (2023–2025), with additional recommendations spanning consumer products, toxic tort, automotive, and general commercial disputes. Forbes recognized him as “best in state” in Georgia — the only product liability lawyer in the state to receive the recognition. He has been selected for inclusion in Best Lawyers for Mass Tort Litigation/Class Actions and Product Liability Litigation – Defendants (2023), is a Fellow of the Litigation Counsel of America, and was named a Distinguished Adviser in Financier Worldwide's Power Players: Product Liability 2023 guide. He received the Defense Research Institute's G. Duffield Smith Outstanding Publication Award. The practice group he chairs was named Law360 “Practice Group of the Year” in 2025 and holds Band 1 (Chambers) and Tier 1 (The Legal 500) group rankings.

Professional Involvement

Chris serves as Publications Vice-Chair of the DRI Drug and Medical Device Steering Committee and served on the Law360 Product Liability Editorial Board (2022–2023). His memberships include the American Bar Association, the New York State Bar Association, the Georgia Bar Association, the Defense Research Institute, Lawyers for Civil Justice, the International Association of Defense Counsel, and the US Chamber of Commerce. His pro bono work includes serving as lead trial counsel for the NAACP and other plaintiffs in the housing discrimination lawsuit Fair Housing in Huntington Committee v. Town of Huntington (E.D.N.Y. 2014).

Experience

Chris is lead global strategic and coordination counsel for Bayer in a mass tort involving a contraceptive medical device spanning five continents and more than a dozen countries, in which the defense has a near-100% success rate with more than 150 favorable findings, including a complete defense judgment after a class action trial in the Supreme Court of Victoria in Melbourne, Australia. He is national trial counsel for Hankook Tire, with product liability trials in Arkansas, Missouri, North Carolina, Tennessee, and Virginia (see, e.g., Cone v. Hankook Tire, Case No. 14-CV-01122 (E.D. Tenn.)); lead national counsel for Bayer in the phenylephrine multi-district litigation, dismissed in full on federal preemption grounds (In re Oral Phenylephrine Marketing and Sales Practices Litigation, 2024 WL 4606818 (E.D.N.Y. Oct. 29, 2024)); lead counsel for Novo Nordisk in product liability litigation involving alleged insulin pen sharing at a Connecticut hospital; global and national counsel for Bayer in Mirena product liability and class action matters, with complete dismissals in California, Washington, and China; and counsel to Pfizer in the Depo-Provera multi-district litigation (In re Depo-Provera (Depot Medroxyprogesterone Acetate) Products Liability Litigation, Case No. 25-md-3140 (N.D. Fla.)). He is co-author of the book Expert Witnesses in Product Liability Cases and of “Turning the Tables: Strategies for Discovering and Using Plaintiffs' Digital Information in Mass Torts” (DRI, October 2024), and his recent speaking engagements include “Digital Evidence at Trial: Mastering Impeachment Strategy and Admissibility Before You Step Into the Courtroom” (myLawCLE, April 2, 2026) and “Digital Evidence & Technology in Mass Tort Litigation” (DLA Piper CLE Program, December 10, 2025).
Breanna Fields

Breanna Fields

DLA Piper LLP

Breanna Fields is a Partner at DLA Piper whose practice focuses on the defense of pharmaceutical, life sciences, and medical device companies in complex product liability and commercial litigation. She regularly represents clients in coordinated proceedings and multidistrict litigations (MDLs), serving as national counsel in high-profile matters involving medical devices and pharmaceutical products.

Recognition & Leadership

Recognized by The Legal 500 United States as Recommended in Product Liability, Mass Tort and Class Action: Pharmaceuticals and Medical Devices – Defense. Served on DLA Piper's Associate Advisory Council. Named to Lawyers for Civil Justice's Class of Rising Stars. Frequent speaker on emerging litigation issues including artificial intelligence in litigation strategy, multidistrict litigation trends, expert admissibility under Federal Rule of Evidence 702, and early case management strategies in MDLs.

Professional Involvement

Active contributor to thought leadership in the product liability and complex litigation space. Co-authored publications in Law360 and for the American Bar Association addressing common-interest privilege and early vetting mechanisms in MDLs. Regularly authors client alerts and insights concerning evidentiary standards, social media liability, and evolving litigation risk. Actively engaged in the broader product liability defense community through speaking roles at national symposia and industry conferences.

Experience

Serves as national counsel in significant multidistrict litigations and coordinated state court proceedings involving pharmaceutical and medical device manufacturers. Representative matters include serving as national counsel for Novo Nordisk in GLP-1 products liability litigation, Medtronic in hernia mesh litigation, Pfizer and Wyeth in proton pump inhibitor litigation, and Bayer in contraceptive device litigation. Has contributed to defense victories including summary judgment outcomes in complex MDL proceedings. Prior to joining DLA Piper, practiced complex commercial and securities litigation at an international law firm in New York. Externed for the Honorable Laura Taylor Swain of the United States District Court for the Southern District of New York and argued an appellate brief through the Center for Appellate Litigation.
Dani Morrison

Dani Morrison

DLA Piper LLP

Dani Morrison is an Associate at DLA Piper whose practice focuses on the defense of pharmaceutical and life sciences companies in complex state and federal litigation, including coordinated product liability and multidistrict mass tort actions. She also advises consumer goods companies on strategic market entry across multiple international jurisdictions, including regulatory, corporate governance, and commercial considerations.

Education & Credentials

J.D. and M.S., magna cum laude, from Syracuse University. Admitted to practice in Pennsylvania, multiple federal district courts in Pennsylvania, the Third and Fifth Circuits, the Supreme Court of Pennsylvania, and the District of Columbia Court of Appeals.

Recognition & Leadership

Active contributor to product liability and mass tort thought leadership. Has authored and co-authored publications for Lexology and the American Bar Association addressing emerging product liability risks, federal removal strategy, and evolving litigation doctrines. Regularly participates in DLA Piper's Product Liability Symposia and CLE programming, including panels on mass tort strategy, multidistrict litigation management, and preemption.

Professional Involvement

Maintains an active pro bono practice, representing clients in constitutional matters and veterans seeking upgrades to their military discharge status.

Experience

Represents pharmaceutical and life sciences companies in coordinated state and federal product liability proceedings and mass tort actions. Experience spans pretrial strategy, expert development, dispositive motions, mediation, and trial preparation. Advises companies navigating international expansion and regulatory frameworks in consumer markets, integrating litigation risk assessment with broader business objectives. Prior to joining DLA Piper, clerked for the Honorable Darnell Jones, II of the United States District Court for the Eastern District of Pennsylvania and for the Honorable Theodore A. McKee of the United States Court of Appeals for the Third Circuit.
Alyssa Moscarino

Alyssa Moscarino

Benesch Friedlander Coplan & Aronoff LLP

Alyssa Moscarino is a trial lawyer and Partner at Benesch whose practice focuses on high-stakes, complex commercial litigation across a range of industries. She represents clients in business-to-business disputes involving breach of contract, mass torts, defamation, trade secrets, products liability, and other complex claims, managing all phases of litigation from initial intake through trial and arbitration.

Education & Credentials

J.D. from the University of Miami School of Law in 2015. B.A. from the University of Texas in 2012.

Recognition & Leadership

Under her leadership as Co-Chair of Benesch's Hiring Committee, Benesch's summer program has been nationally recognized by The American Lawyer as a Top 40 Summer Associate Program.

Professional Involvement

Serves as Co-Chair of Benesch's Hiring Committee, overseeing recruitment and hiring for the firm's summer associate program and helping mentor incoming associates through litigation training and professional development initiatives. Serves on the firm's litigation recruiting committee and contributes to Benesch's diversity and inclusion fellowship selection process. Provides clients with practical guidance on risk management and compliance strategies, advising on pre-litigation planning and best practices to minimize potential exposure.

Experience

Served as trial counsel for Professional Bull Riders, LLC in the Chapter 11 proceedings involving Merit Street Media, Inc., co-founded by Dr. Phil, where her client prevailed on all issues after a multi-day bench trial. Played a key role in defending Polaris, a major off-road vehicle manufacturer, in more than three dozen product liability lawsuits nationwide, successfully resolving those cases through favorable settlements or summary judgment dismissals. Prepared and defended the directors and officers of Smartmatic in highly publicized multibillion-dollar defamation actions related to the 2020 United States Presidential Election, and deposed former National Security Advisor General Michael Flynn in one of those matters. Was a member of the trial team in a significant federal defamation and First Amendment case in Cleveland.
Nick Secco

Nick Secco

Benesch Friedlander Coplan & Aronoff LLP

Nick Secco is a nationally recognized trial lawyer and Partner at Benesch who serves as Chair of the firm’s Trial Practice Group. His practice focuses on complex commercial litigation, toxic tort matters, and environmental claims, regularly representing clients in high-stakes disputes across federal courts, arbitration proceedings, and other complex litigation forums.

Education & Credentials

J.D., cum laude, from Northwestern Pritzker School of Law, where he was a member of the Order of the Coif and served as Senior Editor of the Journal of International Law and Business. Received the Bell, Boyd & Lloyd Advocacy Prize for excellence in advocacy. B.A. in Philosophy from Louisiana State University.

Recognition & Leadership

Chambers USA 2025 ranked him as a leading practitioner in General Commercial Litigation, describing him as "brilliant in litigation" and a "fantastic oral advocate." Benchmark Litigation named him a National Litigation Star (2024–2026). Thomson Reuters recognized him as a national Stand-Out Lawyer based on client nominations. The Legal 500 identified him as a leader in Mass Tort and Product Liability Defense, referring to him as a "trial expert." Trials covered by outlets including The Wall Street Journal, The New York Times, The Los Angeles Times, Variety, The American Lawyer, Law360, and the National Law Journal.

Professional Involvement

Chair of Benesch's Trial Practice Group, leading the firm's trial strategy and advocacy efforts across complex litigation matters.

Experience

Has served as trial counsel in numerous high-stakes cases involving significant financial exposure, including federal bench trials, jury trials, and international arbitration proceedings involving environmental claims, breach of contract disputes, and complex commercial litigation. Represented a professional sports league in a widely reported federal bankruptcy trial involving a nine-figure claim against Dr. Phil McGraw and his media platform, securing a ruling that the bankruptcy filing had been made in bad faith. Served as lead trial counsel in major environmental litigation under CERCLA where the government sought more than $130 million in damages. Represented defendants in complex environmental claims involving potential remediation costs approaching one billion dollars.
Christopher G. Campbell

Christopher G. Campbell

DLA Piper

Christopher G. Campbell is a partner at DLA Piper, where he chairs the firm’s Product Liability and Mass Torts group and co-chairs its Product Liability, Mass Torts & Class Actions group. Drawing on 25 years of experience across every phase of mass tort, class action, and complex product liability litigation, he serves as global, national, and trial counsel for major companies in the pharmaceutical, medical device, automotive, industrial equipment, healthcare, consumer goods, and safety equipment industries, and advises on regulatory, communications, and other strategic matters affecting clients’ business interests and reputations. He writes and speaks regularly on digital evidence, expert witnesses, the attorney-client privilege, trial tactics, and class action trends.

Education & Credentials

Chris earned his J.D. from Harvard Law School in 2000, where he served on the Harvard Negotiation Law Review, the International Law Journal, and the Civil Rights-Civil Liberties Law Review and participated in the Ames Moot Court Competition. He holds a B.S. in Philosophy and English from Austin Peay State University (1997), which named him Outstanding Young Alumnus of the Year in 2002. He is admitted to practice in Georgia and New York.

Recognition & Leadership

Chris is ranked by Chambers USA for Nationwide Product Liability & Mass Torts (Band 5, 2025; Band 6, 2023–2024) and is recognized by The Legal 500 United States as a Leading Lawyer in pharmaceutical and medical device product liability defense (2023–2025), with additional recommendations spanning consumer products, toxic tort, automotive, and general commercial disputes. Forbes recognized him as “best in state” in Georgia — the only product liability lawyer in the state to receive the recognition. He has been selected for inclusion in Best Lawyers for Mass Tort Litigation/Class Actions and Product Liability Litigation – Defendants (2023), is a Fellow of the Litigation Counsel of America, and was named a Distinguished Adviser in Financier Worldwide's Power Players: Product Liability 2023 guide. He received the Defense Research Institute's G. Duffield Smith Outstanding Publication Award. The practice group he chairs was named Law360 “Practice Group of the Year” in 2025 and holds Band 1 (Chambers) and Tier 1 (The Legal 500) group rankings.

Professional Involvement

Chris serves as Publications Vice-Chair of the DRI Drug and Medical Device Steering Committee and served on the Law360 Product Liability Editorial Board (2022–2023). His memberships include the American Bar Association, the New York State Bar Association, the Georgia Bar Association, the Defense Research Institute, Lawyers for Civil Justice, the International Association of Defense Counsel, and the US Chamber of Commerce. His pro bono work includes serving as lead trial counsel for the NAACP and other plaintiffs in the housing discrimination lawsuit Fair Housing in Huntington Committee v. Town of Huntington (E.D.N.Y. 2014).

Experience

Chris is lead global strategic and coordination counsel for Bayer in a mass tort involving a contraceptive medical device spanning five continents and more than a dozen countries, in which the defense has a near-100% success rate with more than 150 favorable findings, including a complete defense judgment after a class action trial in the Supreme Court of Victoria in Melbourne, Australia. He is national trial counsel for Hankook Tire, with product liability trials in Arkansas, Missouri, North Carolina, Tennessee, and Virginia (see, e.g., Cone v. Hankook Tire, Case No. 14-CV-01122 (E.D. Tenn.)); lead national counsel for Bayer in the phenylephrine multi-district litigation, dismissed in full on federal preemption grounds (In re Oral Phenylephrine Marketing and Sales Practices Litigation, 2024 WL 4606818 (E.D.N.Y. Oct. 29, 2024)); lead counsel for Novo Nordisk in product liability litigation involving alleged insulin pen sharing at a Connecticut hospital; global and national counsel for Bayer in Mirena product liability and class action matters, with complete dismissals in California, Washington, and China; and counsel to Pfizer in the Depo-Provera multi-district litigation (In re Depo-Provera (Depot Medroxyprogesterone Acetate) Products Liability Litigation, Case No. 25-md-3140 (N.D. Fla.)). He is co-author of the book Expert Witnesses in Product Liability Cases and of “Turning the Tables: Strategies for Discovering and Using Plaintiffs' Digital Information in Mass Torts” (DRI, October 2024), and his recent speaking engagements include “Digital Evidence at Trial: Mastering Impeachment Strategy and Admissibility Before You Step Into the Courtroom” (myLawCLE, April 2, 2026) and “Digital Evidence & Technology in Mass Tort Litigation” (DLA Piper CLE Program, December 10, 2025).
Breanna Fields

Breanna Fields

DLA Piper LLP

Breanna Fields is a Partner at DLA Piper whose practice focuses on the defense of pharmaceutical, life sciences, and medical device companies in complex product liability and commercial litigation. She regularly represents clients in coordinated proceedings and multidistrict litigations (MDLs), serving as national counsel in high-profile matters involving medical devices and pharmaceutical products.

Recognition & Leadership

Recognized by The Legal 500 United States as Recommended in Product Liability, Mass Tort and Class Action: Pharmaceuticals and Medical Devices – Defense. Served on DLA Piper's Associate Advisory Council. Named to Lawyers for Civil Justice's Class of Rising Stars. Frequent speaker on emerging litigation issues including artificial intelligence in litigation strategy, multidistrict litigation trends, expert admissibility under Federal Rule of Evidence 702, and early case management strategies in MDLs.

Professional Involvement

Active contributor to thought leadership in the product liability and complex litigation space. Co-authored publications in Law360 and for the American Bar Association addressing common-interest privilege and early vetting mechanisms in MDLs. Regularly authors client alerts and insights concerning evidentiary standards, social media liability, and evolving litigation risk. Actively engaged in the broader product liability defense community through speaking roles at national symposia and industry conferences.

Experience

Serves as national counsel in significant multidistrict litigations and coordinated state court proceedings involving pharmaceutical and medical device manufacturers. Representative matters include serving as national counsel for Novo Nordisk in GLP-1 products liability litigation, Medtronic in hernia mesh litigation, Pfizer and Wyeth in proton pump inhibitor litigation, and Bayer in contraceptive device litigation. Has contributed to defense victories including summary judgment outcomes in complex MDL proceedings. Prior to joining DLA Piper, practiced complex commercial and securities litigation at an international law firm in New York. Externed for the Honorable Laura Taylor Swain of the United States District Court for the Southern District of New York and argued an appellate brief through the Center for Appellate Litigation.
Dani Morrison

Dani Morrison

DLA Piper LLP

Dani Morrison is an Associate at DLA Piper whose practice focuses on the defense of pharmaceutical and life sciences companies in complex state and federal litigation, including coordinated product liability and multidistrict mass tort actions. She also advises consumer goods companies on strategic market entry across multiple international jurisdictions, including regulatory, corporate governance, and commercial considerations.

Education & Credentials

J.D. and M.S., magna cum laude, from Syracuse University. Admitted to practice in Pennsylvania, multiple federal district courts in Pennsylvania, the Third and Fifth Circuits, the Supreme Court of Pennsylvania, and the District of Columbia Court of Appeals.

Recognition & Leadership

Active contributor to product liability and mass tort thought leadership. Has authored and co-authored publications for Lexology and the American Bar Association addressing emerging product liability risks, federal removal strategy, and evolving litigation doctrines. Regularly participates in DLA Piper's Product Liability Symposia and CLE programming, including panels on mass tort strategy, multidistrict litigation management, and preemption.

Professional Involvement

Maintains an active pro bono practice, representing clients in constitutional matters and veterans seeking upgrades to their military discharge status.

Experience

Represents pharmaceutical and life sciences companies in coordinated state and federal product liability proceedings and mass tort actions. Experience spans pretrial strategy, expert development, dispositive motions, mediation, and trial preparation. Advises companies navigating international expansion and regulatory frameworks in consumer markets, integrating litigation risk assessment with broader business objectives. Prior to joining DLA Piper, clerked for the Honorable Darnell Jones, II of the United States District Court for the Eastern District of Pennsylvania and for the Honorable Theodore A. McKee of the United States Court of Appeals for the Third Circuit.
Alyssa Moscarino

Alyssa Moscarino

Benesch Friedlander Coplan & Aronoff LLP

Alyssa Moscarino is a trial lawyer and Partner at Benesch whose practice focuses on high-stakes, complex commercial litigation across a range of industries. She represents clients in business-to-business disputes involving breach of contract, mass torts, defamation, trade secrets, products liability, and other complex claims, managing all phases of litigation from initial intake through trial and arbitration.

Education & Credentials

J.D. from the University of Miami School of Law in 2015. B.A. from the University of Texas in 2012.

Recognition & Leadership

Under her leadership as Co-Chair of Benesch's Hiring Committee, Benesch's summer program has been nationally recognized by The American Lawyer as a Top 40 Summer Associate Program.

Professional Involvement

Serves as Co-Chair of Benesch's Hiring Committee, overseeing recruitment and hiring for the firm's summer associate program and helping mentor incoming associates through litigation training and professional development initiatives. Serves on the firm's litigation recruiting committee and contributes to Benesch's diversity and inclusion fellowship selection process. Provides clients with practical guidance on risk management and compliance strategies, advising on pre-litigation planning and best practices to minimize potential exposure.

Experience

Served as trial counsel for Professional Bull Riders, LLC in the Chapter 11 proceedings involving Merit Street Media, Inc., co-founded by Dr. Phil, where her client prevailed on all issues after a multi-day bench trial. Played a key role in defending Polaris, a major off-road vehicle manufacturer, in more than three dozen product liability lawsuits nationwide, successfully resolving those cases through favorable settlements or summary judgment dismissals. Prepared and defended the directors and officers of Smartmatic in highly publicized multibillion-dollar defamation actions related to the 2020 United States Presidential Election, and deposed former National Security Advisor General Michael Flynn in one of those matters. Was a member of the trial team in a significant federal defamation and First Amendment case in Cleveland.
Nick Secco

Nick Secco

Benesch Friedlander Coplan & Aronoff LLP

Nick Secco is a nationally recognized trial lawyer and Partner at Benesch who serves as Chair of the firm’s Trial Practice Group. His practice focuses on complex commercial litigation, toxic tort matters, and environmental claims, regularly representing clients in high-stakes disputes across federal courts, arbitration proceedings, and other complex litigation forums.

Education & Credentials

J.D., cum laude, from Northwestern Pritzker School of Law, where he was a member of the Order of the Coif and served as Senior Editor of the Journal of International Law and Business. Received the Bell, Boyd & Lloyd Advocacy Prize for excellence in advocacy. B.A. in Philosophy from Louisiana State University.

Recognition & Leadership

Chambers USA 2025 ranked him as a leading practitioner in General Commercial Litigation, describing him as "brilliant in litigation" and a "fantastic oral advocate." Benchmark Litigation named him a National Litigation Star (2024–2026). Thomson Reuters recognized him as a national Stand-Out Lawyer based on client nominations. The Legal 500 identified him as a leader in Mass Tort and Product Liability Defense, referring to him as a "trial expert." Trials covered by outlets including The Wall Street Journal, The New York Times, The Los Angeles Times, Variety, The American Lawyer, Law360, and the National Law Journal.

Professional Involvement

Chair of Benesch's Trial Practice Group, leading the firm's trial strategy and advocacy efforts across complex litigation matters.

Experience

Has served as trial counsel in numerous high-stakes cases involving significant financial exposure, including federal bench trials, jury trials, and international arbitration proceedings involving environmental claims, breach of contract disputes, and complex commercial litigation. Represented a professional sports league in a widely reported federal bankruptcy trial involving a nine-figure claim against Dr. Phil McGraw and his media platform, securing a ruling that the bankruptcy filing had been made in bad faith. Served as lead trial counsel in major environmental litigation under CERCLA where the government sought more than $130 million in damages. Represented defendants in complex environmental claims involving potential remediation costs approaching one billion dollars.

Credits by state

AK2.0
AL2.0
AR2.0
AZ2.0
CA2.0
CO2.0
CT2.0
DC
DE2.0
FL2.5
GA2.0
HI2.0
IA2.0
ID2.0
IL2.0
IN2.0
KS2.0
KY2.0
LA2.0
MA2.0
MD2.0
ME2.0
MI2.0
MN2.0
MO2.4
MS2.0
MT2.0
NC2.0
ND2.0
NE2.0
NH120.0
NJ2.4
NM2.0
NV2.0
NY2.0
OH2.0
OK2.0
OR2.0
PA2.0
RI2.0
SC2.0
SD2.0
TN2.0
TX2.0
UT2.0
VA2.0
VT2.0
WA2.0
WI2.0
WV2.4
WY2.0

Upcoming Live Online CLE Broadcasts

1000+

Live stream programs

24/7

Access to live webinars & recordings

70,000+

Trusted by Legal Professionals

1000+

Live stream programs

24/7

Access to live webinars & recordings

70,000+

Trusted by Legal Professionals

1000+

Live stream programs

24/7

Access to live webinars & recordings

10,000+

Trusted by Legal Professionals

1000+

Live stream programs

24/7

Access to live webinars & recordings

70,000+

Trusted by Legal Professionals

MCLE Credits

Alabama
Approved
Alaska
Approved
Arizona
Approved
Arkansas
Approved
California
Approved
Colorado
Pending
Connecticut
Approved
Delaware
Pending
District of Columbia
No Required
Florida
Approved
Georgia
Approved
Hawaii
Approved
Idaho
Pending
Illinois
Approved
Indiana
Pending
Iowa
Pending
Kansas
Pending
Kentucky
Pending
Louisiana
Pending
Maine
Pending
Maryland
No Required
Massachusetts
No Required
Michigan
No Required
Minnesota
Approved
Mississippi
Pending
Missouri
Approved
Montana
Approved
Nebraska
Pending
Nevada
Approved
New Hampshire
Approved
New Jersey
Approved
New Mexico
Approved
New York
Approved
North Carolina
Pending
North Dakota
Approved
Ohio
Approved
Oklahoma
Pending
Oregon
Pending
Pennsylvania
Approved
Rhode Island
Pending
South Carolina
Pending
South Dakota
No Required
Tennessee
Approved
Texas
Approved
Utah
Pending
Vermont
Approved
Virginia
Not Eligible
Washington
Approved
West Virginia
Pending
Wisconsin
Approved
Wyoming
Pending

Alabama

Requirements

The Alabama State Bar MCLE Commission requires attorneys to complete 12 credits, including 1 ethics, by December 31 of each year. All credits must be reported by February 15 of the following year. A maximum of 12 credits, including 1 ethics credit, may be carried over for 1 year only.  

Formats

  • Attorneys can earn unlimited “live” credit through live seminars, live webcasts, and co-sponsored locations with MyLAWCLE-Alabama approved programs
  • Attorneys are limited to 6 credits per compliance period of “online” programs through MyLAwCLE On-Demand programs